(Adds details, background)
By David Shepardson
WASHINGTON, Oct 15 (Reuters) - The U.S. Centers for Disease Control and Prevention (CDC) said late on Friday that it will accept mixed-dose coronavirus vaccines from international travelers, a boost to travelers from Canada and other places.
The CDC said last week that https://www.reuters.com/world/us/us-will-accept-who-approved-covid-19-vaccines-international-visitors-2021-10-08 it would accept any vaccine authorized for use by U.S. regulators or the World Health Organization. "While CDC has not recommended mixing types of vaccine in a primary series, we recognize that this is increasingly common in other countries so should be accepted for the interpretation of vaccine records," a CDC spokeswoman said.
The White House said Friday the new vaccine requirements for foreign nationals traveling to the United States will begin Nov. 8 for visitors crossing at land borders as well as international air travelers.
Representative Brian Higgins, a New York Democrat representing a district along the Canadian border, had on Friday asked the CDC if it would accept the mixed vaccine doses noting "nearly four million Canadians, equivalent to 10% of their fully vaccinated population, have received mixed doses of the available mRNA COVID-19 vaccines – this includes the AstraZeneca vaccine."
The CDC said the vaccines approved by the Food and Drug Administration (FDA) for use, as well as those authorized by the WHO, will https://covid19.trackvaccines.org/agency/who be accepted for entry into the United States, including the AstraZeneca vaccine.
The CDC said "individuals who have any combination of two doses of an FDA approved/authorized or WHO emergency use listed COVID-19 two-dose series are considered fully vaccinated."
The CDC plans to answer other questions and release a contact tracing order for international air visitors by Oct. 25. (Reporting by David Shepardson; Editing by Leslie Adler and Aurora Ellis)